Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK/T cell lymphoma patients

Intervirology

Volumn 50, Issue 5, 2007, Pages 319-322

  Nagamine, Masayoshi ^a   Kishibe, Kan ^a   Takahara, Miki ^a   Nagato, Toshihiro ^a   Ishii, Hideyuki ^a   Bandoh, Nobuyuki ^a   Ogino, Takeshi ^a   Harabuchi, Yasuaki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

CTL epitope; Cytotoxic T cell; Epstein Barr virus; Genotypes; Japanese; LMP2A; Nasal NK T cell lymphoma

Indexed keywords

AMINO ACID; EPITOPE; SERINE; THREONINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ARTICLE; BLOOD; CARCINOGENESIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; ETHNICITY; FEMALE; GENE; GENE SEQUENCE; GEOGRAPHY; HUMAN; LMP2A GENE; MALE; NATURAL KILLER T CELL; PRIORITY JOURNAL; RACE; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIGENS, VIRAL; ASIAN CONTINENTAL ANCESTRY GROUP; EPITOPES, T-LYMPHOCYTE; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MUTATION, MISSENSE; NOSE NEOPLASMS; SEQUENCE ANALYSIS, DNA; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 35549001029     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106462     Document Type: Article

References (12)

1. Yamanaka N, Kataura A, Sambe S, Minase T, Ishii Y: Midfacial T cell lymphoma: characterization by monoclonal antibodies. Ann Otol Rhinol Laryngol 1985;94:207-211.
2. Harabuchi Y, Imai S, Wakashima J, Hirao M, Kataura A, Osato T, Kon S: Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer 1996;77:2137-2149.
3. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC: Report of the workshop on nasal and related extranodal angiocentric t/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-111.
4. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335:128-130.
5. Minarovits J, Hu LF, Imai S, Harabuchi Y, Kataura A, Minarovits-Kormuta S, Osato T, Klein G: Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J Gen Virol 1994;75(Pt 1):77-84.
6. Chiang AK, Tao Q, Srivastava G, Ho FC: Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 1996;68:285-290.
7. van Gorp J, Brink A, Oudejans JJ, van den Brule AJ, van den Tweel JG, Jiwa NM, de Bruin PC, Meijer CJ: Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas. J Clin Pathol 1996;49:72-76.
8. Nagamine M, Takahara M, Kishibe K, Nagato T, Ishii H, Bandoh N, Ogino T, Harabuchi Y: Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma. Virus Genes 2007;34:47-54.
9. Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB: Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J Immunol 1997;158:3325-3334.
10. Tanaka M, Kawaguchi Y, Yokofujita J, Takagi M, Eishi Y, Hirai K: Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan. Virus Genes 1999;19:103-111.
11. Lautscham G, Haigh T, Mayrhofer S, Taylor G, Croom-Carter D, Leese A, Gadola S, Cerundolo V, Rickinson A, Blake N: Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2. J Virol 2003;77:2757-2761.
12. Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB: HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol 1993;67:7428-7435.